Blocking the expansion of BCSCs through inhibition of the HMGCS1 gene could be a more efficient approach to control the over-production of isoprenoids compared to standard doses of statins, thereby reducing the proliferation of progenitor cells and cancer development. Here, HMGCS1 is linked to cancer.